Hyster-Yale Inc. Class A common stock (HY)
Slow GrowerFairStock Score: 30/100 — RISKY
Key Financials
| Current Price | $35.74 |
| Market Cap | $713M |
| P/E Ratio | -6.38 |
| ROE | -19.79% |
| Dividend Yield | 4.19% |
| Sector | Industrials |
Strengths
- Generates $33 million in annual free cash flow (4.7% yield on market cap)
- Attractive 4.0% dividend yield providing steady income returns
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Revenue declining at 13.5% year-over-year signals potential demand weakness or market share loss
- Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of 1.1 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Hyster-Yale Inc. Class A common stock is a micro-cap industrials company valued at $713 million. Revenue stands at $3.7 billion, though the company is currently unprofitable. From a quality standpoint, Hyster-Yale shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 1.1 warrants caution. On valuation, the stock is solid 4.6% FCF yield. Growth dynamics show revenue growing at -13.5% and profit growth of -609.7%. The 4.0% dividend yield adds an income component for patient holders. Our composite FairStock Score of 30/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $33 million in annual free cash flow (4.7% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer